Who receives a medical evaluation for infertility in the United States

Sunday, May 1, 2016
In addition to financial access influencing who receives a medical evaluation for infertility, demographic and healthy lifestyle characteristics are associated with a medical evaluation for infertility among infertile women.

Read More

Addressing the needs of fertility treatment patients and their partners Are they informed of and do they receive mental health services

Thursday, March 3, 2016

Authors:
Lauri A. Pasch, Ph.D., Sarah Holley, Ph.D., Maria E.…

Read More

Access to fertility services by transgender persons An Ethics Committee opinion

Thursday, October 29, 2015
This statement explores the provision of fertility services to transgender persons.

Read More

Subclinical hypothyroidism in the infertile female population A guideline

Tuesday, September 1, 2015
This guideline document reviews the definition and treatment recommendation for subclinical hypothyroidism in the infertile female population.

Read More

Preconception risk stratification before fertility care

Monday, June 29, 2015

Authors:
Kristi S. Borowski, M.D., Brian C.…

Read More

Prevalence and predictors of major depressive disorder for fertility treatment patients and their partners

Wednesday, April 29, 2015
Major depressive disorder (MDD) is highly prevalent during fertility treatment. A history of MDD increases risk of MDD during treatment, even after controlling for commonly assessed risk factors at treatment entry.

Read More

Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers

Wednesday, April 29, 2015
In a cohort of 1,073 BRCA mutation carriers, fertility treatments were not found to be risk modifiers for invasive epithelial ovarian cancer.

Read More

Use of fertility treatment modalities in a large United States cohort of professional women

Sunday, June 1, 2014
Approximately 94% of women using fertility treatment used clomiphene, with smaller proportions using gonadotropin alone, intrauterine insemination, and in vitro fertilization. These patterns varied by financial, biologic, and temporal factors.

Read More

Fertility treatment and childhood cancer risk a systematic meta analysis

Friday, June 28, 2013
In this systematic meta-analysis of both cohort and case-control studies, published through September 2012, we found an increased risk for cancer among children born after fertility treatment.

Read More

Posthumous collection and use of reproductive tissue a committee opinion

Friday, May 31, 2013
The ethical implications of the use of posthumously collected reproductive tissue are discussed.

Read More

Fertility treatment when the prognosis is very poor or futile: a committee opinion

Tuesday, June 12, 2012
The ethical considerations of providing fertility treatment to patients when the prognosis is very poor or futile are discussed.

Read More

Maternal characteristics and twin gestation outcomes over 10 years: Impact of conception methods

Thursday, June 7, 2012
Twin gestations after fertility treatments are associated significantly with older age, higher prematurity rate, cesarean delivery, and more obstetric complications when compared with those conceived spontaneously.

Read More

Impact of infertility regimens on breast cancer cells: follicle-stimulating hormone and luteinizing hormone lack a direct effect on breast cell proliferation in vitro

Tuesday, May 29, 2012
Treatment of cultured normal and malignant breast cells with follicle-stimulating hormone, luteinizing hormone, and human chorionic gonadotropin did not result in cell proliferation or growth.

Read More

Translate »